Radiofrequency ablation for benign aldosterone-producing adenoma: A scarless technique to an old disease

Annals of Surgery

Volumn 252, Issue 6, 2010, Pages 1058-1064

  Liu, Shirley Yuk Wah ^a   Ng, Enders Kwok Wai ^a   Lee, Paul Sing Fun ^a   Wong, Simon Kin Hung ^a   Chiu, Philip Wai Yan ^a   Mui, Wilfred Lik Man ^a   So, Wing Yee ^a   Chow, Francis Chun Chung ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANTIHYPERTENSIVE AGENT; POTASSIUM; RENIN;

ADENOMA; ADRENAL CORTEX ADENOMA; ADRENALECTOMY; ADULT; ALDOSTERONE PRODUCING ADENOMA; ARTICLE; BENIGN TUMOR; BLOOD PRESSURE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ELECTRODE; FEMALE; FOLLOW UP; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; LAPAROSCOPIC SURGERY; MALE; MEDICAL INSTRUMENTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR VOLUME;

ADENOMA; ADRENAL GLAND NEOPLASMS; ADULT; CATHETER ABLATION; COHORT STUDIES; FEMALE; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 78650151443     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318f66936     Document Type: Article

References (26)

1. Conn JW. Presidential address, part II: primary aldosteronism, a new clinical syndrome. J Lab Clin Med. 1955;45:3-17.
2. Young WF Jr. Primary aldosteronism: a common and curable form of hypertension. Cardiol Rev. 1999;7:207-214.
3. Bravo EL, Tarazi RC, Dustan HP, et al. The changing clinical spectrum of primary aldosteronism. Am J Med. 1983;74:641-651. (Pubitemid 13125982)
4. Assalia A, Gagner M. Laparoscopic adrenalectomy. Br J Surg. 2004;91:1259-1274. (Pubitemid 39331450)
5. Rossi R, Savastano S, Tommaselli AP, et al. Percutaneous computed tomography-guided ethanol injection in aldosterone-producing adrenocorti-cal adenoma. Eur J Endocrinol. 1995;132:302-305.
6. Minowada S, Enomoto Y, Korenaga T, et al. CT-guided acetic acid injection therapy for aldosterone-producing adrenocortical adenoma: a preliminary report of three cases. Endocr J. 2000;47:185-189. (Pubitemid 30399425)
7. Hokotate H, Inoue H, Baba Y, et al. Aldosteronomas: experience with supers-elective adrenal arterial embolization in 33 cases. Radiology. 2003;227:400-406.
8. Shetty SK, Rosen MP, Raptopoulos V, Goldberg SN. Cost-effectiveness of percutaneous radiofrequency ablation for malignant hepatic neoplasms. J Vasc Interv Radiol. 2001;12:823-833. (Pubitemid 32642432)
9. McAchran SE, Lesani OA, Resnick MI. Radiofrequency ablation of renal tumors: past, present and future. Urology. 2005;66:15-22. (Pubitemid 41356554)
10. Suh R, Reckamp K, Zeidler M, Cameron R. Radiofrequency ablation in lung cancer: promising results in safety and efficacy. Oncology. 2005;19:12-21.
11. Brown DB. Concepts, considerations, and concerns on the cutting edge of radiofrequency ablation. J Vasc Interv Radiol. 2005;16:597-613. (Pubitemid 40647204)
12. Wood BJ, Ramkaransingh JR, Fojo T, et al. Percutaneous tumor ablation with radiofrequency. Cancer. 2002;94:443-451. (Pubitemid 34081375)
13. Wood BJ, Abraham J, Hvizda JI, et al. Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer. 2003;97:554-560. (Pubitemid 36125832)
14. Mayo-Smith WW. Dupuy DE. Adrenal neoplasms: CT-guided radiofrequency ablation- preliminary results. Radiology. 2004;231:225-230. (Pubitemid 38375432)
15. Lo WK, Vansonnenberg E, Shankar S, et al. Percutaneous CT-guided radiofre-quency ablation of symptomatic bilateral adrenal metastases in a single session. J Vasc Interv Radiol. 2006;17:175-179. (Pubitemid 44392049)
16. Carrafiello G, Lagana D, Recaldini C, et al. Imaging-guided percutaneous radiofrequency ablation of adrenal metastases: preliminary results at a single institution with a single device. Cardiovasc Interv Radiol. 2008;31:762-767.
17. Onik G, Onik C, Medary I, et al. Life threatening hypertensive crises in two patients undergoing hepatic radiofrequency ablation. AJR Am J Roentgenol. 2003;181:495-497. (Pubitemid 36909497)
18. Chini EN, Brown MJ, Farrell MA, et al. Hypertensive crisis in a patient undergoing percutaneous radiofrequency ablation of an adrenal mass under general anaesthesia. Anesth Analg. 2004;99:1867-1869. (Pubitemid 39551938)
19. Al-Shaikh AA, Al-Rawas MM, Al-Asnag MA. Primary hyperaldos-teronism treated by radiofrequency ablation. Saudi Med J. 2004;25: 1711-1714. (Pubitemid 39646654)
20. Johnson SP, Bagrosky BM, Mitchell EL, et al. CT-guided radiofrequency ablation of an aldosterone-secreting primary adrenal tumor in a surgically unfit patient. J Vasc Interv Radiol. 2008;19:1115-1117.
21. Arima K, Yamakado K, Suzuki R, et al. Image-guided radiofrequency ablation for adrenocortical adenoma with Cushing syndrome: outcomes after mean follow-up of 33 months. Urology. 2007;70:407-411. (Pubitemid 47464495)
22. Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266-3281.
23. Gagner M, Lacroix A, Bolte E. Laparoscopic adrenalectomy in Cushing's syndrome and pheochromocytoma. N Engl J Med. 1992;327:1033.
24. Hellman P, Ladjevardi S, Skogseid B, et al. Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors. World J Surg. 2002;26:1052-1056. (Pubitemid 36920308)
25. Venkatesan AM, Locklin J, Lai EW, et al. Radiofrequency ablation of metastatic pheochromocytoma. J Vasc Interv Radiol. 2009;20:1483-1490.
26. Park HS, Roman SA, Sosa JA. Outcomes from 3144 adrenalectomies in the United States. Arch Surg. 2009;144:1060-1067.